Cargando…

High Content Screening in Neurodegenerative Diseases

The functional annotation of genomes, construction of molecular networks and novel drug target identification, are important challenges that need to be addressed as a matter of great urgency(1-4). Multiple complementary 'omics' approaches have provided clues as to the genetic risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jain, Shushant, van Kesteren, Ronald E., Heutink, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MyJove Corporation 2012
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369774/ https://www.ncbi.nlm.nih.gov/pubmed/22257990 http://dx.doi.org/10.3791/3452

Ejemplares similares

Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders
por: Morant, Anne Vinther, et al.
Publicado: (2019)

Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
por: Mahley, Robert W.
Publicado: (2016)

Antisense Transcription in Loci Associated to Hereditary Neurodegenerative Diseases
por: Zucchelli, Silvia, et al.
Publicado: (2019)

The development of the Screening of Visual Complaints questionnaire for patients with neurodegenerative disorders: Evaluation of psychometric features in a community sample
por: Huizinga, Famke, et al.
Publicado: (2020)

High-Throughput Screening Platforms in the Discovery of Novel Drugs for Neurodegenerative Diseases
por: Aldewachi, Hasan, et al.
Publicado: (2021)

Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson’s Disease
por: Dijkstra, Anke A., et al.
Publicado: (2015)

Recent Advances in High-Content Imaging and Analysis in iPSC-Based Modelling of Neurodegenerative Diseases
por: Menduti, Giovanna, et al.
Publicado: (2023)

Stem Cells in Drug Screening for Neurodegenerative Disease
por: Kim, Hyun-Jung, et al.
Publicado: (2012)

Increasing the Content of High-Content Screening: An Overview
por: Singh, Shantanu, et al.
Publicado: (2014)

Neurodegenerative diseases-Caps: a capsule network based early screening system for the classification of neurodegenerative diseases
por: Bhatele, Kirti Raj, et al.
Publicado: (2022)

FAIR High Content Screening in Bioimaging
por: Hosseini, Rohola, et al.
Publicado: (2023)

Recent Medicinal Chemistry Studies against Neurodegenerative Diseases
por: Scotti, Luciana, et al.
Publicado: (2023)

mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases
por: Shang, Dehao, et al.
Publicado: (2023)

Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms
por: van Ham, Tjakko J, et al.
Publicado: (2009)

Age-Related Macular Degeneration and Its Association With Neurodegenerative Disorders
por: Mody, Sankalp, et al.
Publicado: (2023)

Advances in Neurodegenerative Diseases
por: Van Schependom, Jeroen, et al.
Publicado: (2023)

Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes
por: Grafton, Francis, et al.
Publicado: (2021)

FADS2 Genetic Variance in Combination with Fatty Acid Intake Might Alter Composition of the Fatty Acids in Brain
por: Rizzi, Thais S., et al.
Publicado: (2013)

Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders
por: Saponaro, Federica, et al.
Publicado: (2020)

Probiotics for Neurodegenerative Diseases: A Systemic Review
por: Ojha, Sandhya, et al.
Publicado: (2023)

Reliability of measuring regional callosal atrophy in neurodegenerative diseases
por: Van Schependom, Jeroen, et al.
Publicado: (2016)

High-content imaging-based pooled CRISPR screens in mammalian cells
por: Yan, Xiaowei, et al.
Publicado: (2021)

Ultrasound of the neonatal hip as a screening tool for DDH: how to screen and differences in screening programs between European countries
por: Kilsdonk, Iris, et al.
Publicado: (2021)

Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies
por: Mátis, Dóra, et al.
Publicado: (2023)

Inflammasomes in neuroinflammatory and neurodegenerative diseases
por: Voet, Sofie, et al.
Publicado: (2019)

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis
por: Rühmann, Broder, et al.
Publicado: (2016)

Policy analysis in the field of rare diseases in China: a combined study of content analysis and Bibliometrics analysis
por: Li, Xiaotao, et al.
Publicado: (2023)

Evidence of the content validity, acceptability, and feasibility of a new Patient-Reported Impact of Dermatological Diseases measure
por: Pattinson, Rachael, et al.
Publicado: (2023)

Neuron-based high-content assay and screen for CNS active mitotherapeutics
por: Varkuti, Boglarka H., et al.
Publicado: (2020)

Patient-specific monocyte-derived microglia as a screening tool for neurodegenerative diseases
por: Quek, Hazel, et al.
Publicado: (2022)

Beyond dentistry: could prevention and screening for neurodegenerative diseases start in the dental office?
por: Buccellato, Francesca R., et al.
Publicado: (2023)

Expanding Arsenal against Neurodegenerative Diseases Using Quercetin Based Nanoformulations: Breakthroughs and Bottlenecks
por: Vishwas, Sukriti, et al.
Publicado: (2023)

TREM2 in Neurodegenerative Diseases
por: Jay, Taylor R., et al.
Publicado: (2017)

Automated microscopy for high-content RNAi screening
por: Conrad, Christian, et al.
Publicado: (2010)

Metadata management for high content screening in OMERO
por: Li, Simon, et al.
Publicado: (2016)

High-content CRISPR screening in tumor immunology
por: Holcomb, Erin A., et al.
Publicado: (2022)

Viral-induced neurodegenerative disease
por: J Buchmeier, Michael, et al.
Publicado: (1999)

Oncogenic Pathways in Neurodegenerative Diseases
por: Varela, Luis, et al.
Publicado: (2022)

Oxidative stress in neurodegenerative disease: causation or association?
por: Van Raamsdonk, Jeremy M., et al.
Publicado: (2017)

Aquaporins and Neurodegenerative Diseases
por: Foglio, Eleonora, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dvtnh1cg03tc6mskbdbm02but8